173 completed, 72 recruiting, 51 unknown, 39 terminated. 409 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 409 | Completed 173, Recruiting 72, Unknown 51, Terminated 39, Not yet recruiting 29, Withdrawn 22, Active not recruiting 17, Enrolling by invitation 5, Suspended 1 |
Follow Brain Diseases: new trials by email Literature Review of Brain Diseases trials Research Report on Brain Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria GS1168 injection - Phenylketonuria (PKU) | Early Phase 1 | Not yet recruiting | Gritgen Therapeutics Co., Ltd. | 9 | 2027-12-31 | 2026-09-10 |
| Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Human-Machine Interaction in Chronic Stroke Neuromuscular coordination enhancement (NICE) intervention, EMG Amplitude Biofeedback Exercise - Chronic Stroke-related Upper-extremity Motor Impairment, Motor Module-guided Rehabilitation Targeting Impaired Intermuscular Coordination and Motor Recovery | Early Phase 1 | Not yet recruiting | University of Houston | 48 | 2027-08-01 | 2026-06-18 |
| Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques Pegulicianine, Placebo - Carotid Artery Diseases, Peripheral Arterial Disease | Early Phase 1 | Not yet recruiting | Massachusetts General Hospital | 25 | 2027-06-01 | 2026-11-10 |
| hCG Treatment for Rehabilitation From a TBI Ovidrel, Placebo - Traumatic Brain Injury | Early Phase 1 | Not yet recruiting | VA Office of Research and Development | 50 | 2027-01-01 | 2026-10-19 |
| Cell-Based Therapy for White Matter Repair in Periventricular Leukomalacia Investigational Combination Product - Periventricular Leukomalacia, White Matter Disease | Early Phase 1 | Withdrawn | MGAM LLC | 2027-01-01 | 2025-07-22 | |
| Cholinergic Enhancement of Theta COBENFY KarXT (50/20 mg), Control - Epilepsy, Seizures | Early Phase 1 | Not yet recruiting | University of Texas Southwestern Medical Center | 50 | 2026-12-01 | 2026-09-29 |
| Bayesian Optimization of DBS for Gait Deep Brain Stimulation - Parkinson Disease (PD) | Early Phase 1 | Recruiting | University of Minnesota | 15 | 2026-12-01 | 2026-09-28 |
| Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence Botulinum Toxin Type A (BoNT-A) - Spasticity, Stroke | Early Phase 1 | Not yet recruiting | Instituto Mexicano del Seguro Social | 200 | 2026-12-01 | 2026-11-04 |
| Exploratory Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease UX-DA003 - PARKINSON DISEASE (Disorder) | Early Phase 1 | Recruiting | The First Affiliated Hospital of Anhui Medical University | 12 | 2026-11-23 | 2026-11-03 |
| Asciminib With or Without Sildenafil for Brain Tumors Asciminib, Sildenafil, Surgical resection or biopsy - Brain Tumor | Early Phase 1 | Not yet recruiting | Washington University School of Medicine | 12 | 2026-10-31 | 2026-09-11 |
| Translational Recording and Characterization of Epilepsy Signals Using Subgaleal EEG During Standard-of-care SEEG Monitoring EEG Record only - Epilepsy (Treatment Refractory) | Early Phase 1 | Not yet recruiting | Adraxe Corp. | 15 | 2026-10-15 | 2026-09-16 |
| Human Cognition During Surgery: Stimulation-based and Cholinergic Modulation Cobenfy KarXT pill (50/20 mg), Placebo - Epilepsy, Essential Tremor | Early Phase 1 | Not yet recruiting | University of Texas Southwestern Medical Center | 30 | 2026-10-01 | 2026-07-23 |
| Mild Cognitive Impairment Community Screening and Early Intervention Via Stem Cell Therapy and Wearable Brain Computer Interface Device. Structured wellness care, Wearable brain-computer interface devices, Stem Cell Therapy - Experimental - Mild Cognitive Impairment (MCI), Early Stages of Cognitive Decline | Early Phase 1 | Not yet recruiting | Noah Tech, Corp. | 600 | 2026-09-01 | 2026-03-10 |
| Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease Norethindrone Acetate-Ethinyl Estradiol - Arginine Vasopressin Deficiency, Oxytocin Deficiency | Early Phase 1 | Recruiting | Massachusetts General Hospital | 20 | 2026-08-17 | 2026-10-26 |
| Test-retest Trial With [11C]MODAG-005 in PD or MSA and AMHC - Pilot Phase [11C]MODAG-005 - Parkinson Disease (PD), MSA - Multiple System Atrophy | Early Phase 1 | Recruiting | MODAG GmbH | 9 | 2026-07-29 | 2026-07-31 |
| Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures Panitumumab-IRDye800 - Meningioma, Glioblastoma | Early Phase 1 | Recruiting | Eben Rosenthal | 30 | 2026-07-07 | 2026-10-16 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations LY-N001 Injection - Parkinson's Disease (PD) | Early Phase 1 | Not yet recruiting | Lingyi Biotech Co., Ltd. | 18 | 2026-07-07 | 2026-07-06 |
| The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy Everolimus - Epilepsy, Drug Resistant | Early Phase 1 | Recruiting | Xuanwu Hospital, Beijing | 5 | 2026-07-01 | 2026-04-07 |
| Expansion Study of ALT001 in Patients With Multiple System Atrophy ALT001 - Multiple System Atrophy | Early Phase 1 | Recruiting | yilong Wang | 60 | 2026-06-15 | 2026-09-09 |
| The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type ALT001 - Multiple System Atrophy - Cerebellar Subtype (MSA-C) | Early Phase 1 | Recruiting | yilong Wang | 20 | 2026-06-10 | 2026-09-09 |
Showing 20 of 409. Sign in to see all of them.
Alzheimer Disease (63) · Brain Neoplasms (62) · Parkinson Disease (57) · Stroke (55) · Brain Injuries, Traumatic (24) · Glioma (21) · Cognitive Dysfunction (17) · Glioblastoma (17) · Epilepsy (16) · Ischemic Stroke (14) · Multiple System Atrophy (11) · Cerebral Palsy (10) · Brain Injuries (8) · Dementia (8) · Drug Resistant Epilepsy (8)
Central Nervous System Diseases (408) · Nervous System Diseases (407) · Neurodegenerative Diseases (137) · Vascular Diseases (98) · Cardiovascular Diseases (97) · Mental Disorders (96) · Cerebrovascular Disorders (89) · Neurocognitive Disorders (88) · Pathological Conditions, Signs and Symptoms (85) · Movement Disorders (83) · Basal Ganglia Diseases (82) · Neoplasms by Site (78) · Neoplasms (77) · Nervous System Neoplasms (77)
Magnetic Resonance Spectroscopy (9) · Sodium Chloride (5) · Temozolomide (5) · florbetapir (5) · Bevacizumab (4) · Botulinum Toxins, Type A (4) · Deep Brain Stimulation (4) · Propranolol (4) · Saline Solution (4) · 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole (3) · Atorvastatin (3) · Biopsy (3) · Dexamethasone (3) · Donepezil (3) · Fluorodeoxyglucose F18 (3)
University of Pennsylvania (7) · University of Texas Southwestern Medical Center (7) · Brigham and Women's Hospital (6) · Massachusetts General Hospital (6) · Mayo Clinic (6) · Xuanwu Hospital, Beijing (6) · Case Comprehensive Cancer Center (5) · National Institute of Neurological Disorders and Stroke (NINDS) (5) · University of Florida (5) · VA Office of Research and Development (5) · Arizona State University (4) · Avid Radiopharmaceuticals (4) · Beijing Tiantan Hospital (4) · CHDI Foundation, Inc. (4) · Institute for Neurodegenerative Disorders (4)
United States (241) · China (59) · Canada (9) · France (8) · Netherlands (8) · Denmark (7) · United Kingdom (7) · Sweden (6) · Egypt (5) · Germany (5) · Spain (5) · Belgium (4) · Israel (4) · Australia (3) · Norway (3)
Danna Jennings, MD (4) · Ela Plow, PhD (3) · Liankun Ren, MD (3) · Maryam Fouladi, MD (3) · Bradley C Lega, MD (2) · Carsten Kock-Jensen, MD (2) · Cristina Sampaio, MD, PhD (2) · David J Nutt, MD (2) · David Sandberg, MD (2) · Irene CM Cortese, M.D. (2) · Jesse C. Dean, PhD (2) · Johannes Jakobsen, MD, DMSc (2)
PMID 10898704, PMID 11571371, PMID 12359244, PMID 18468545, PMID 19138338, PMID 19366446, PMID 20097391, PMID 20185616, PMID 20204561, PMID 20335583, PMID 20360543, PMID 20501908, PMID 21157444, PMID 21368663, PMID 21749363, PMID 22200394, PMID 22459048, PMID 22910531, PMID 22982823, PMID 23559265, PMID 23763450, PMID 23993913, PMID 25013996, PMID 25479121, PMID 25819304, PMID 26084406, PMID 26158265, PMID 26203461, PMID 26276377, PMID 26304864, PMID 26724101, PMID 26800377, PMID 27179600, PMID 27206648, PMID 27512927, PMID 27547509, PMID 27774033, PMID 27814297, PMID 27871449, PMID 28402865, PMID 28538134, PMID 28902040, PMID 28994123, PMID 29114823, PMID 29262425, PMID 29286983, PMID 29540584, PMID 29701252, PMID 29753889, PMID 29882765
K23AG030967 (2), P30CA138292 (2), R15HD114052 (2), 2018 (1), 2023 (1), 2025 (1), I01RX000825 (1), I01RX004545 (1), K23AG057794 (1), P01HL056693 (1), P20GM109040 (1), P30AG072958 (1), P30CA012197 (1), P30CA013330 (1), P30CA014089 (1)